Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to George Bakris

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Bakris, George

Item TypeName
Concept Diabetes Mellitus, Type 1
Concept Diabetes Mellitus, Type 2
Academic Article Angiotensin converting enzyme inhibitors and calcium antagonists alone or combined: does the progression of diabetic renal disease differ?
Academic Article Effects of dihydropyridine calcium antagonists on albuminuria in patients with diabetes.
Academic Article Therapeutic challenges in the obese diabetic patient with hypertension.
Academic Article Predictors of renal and cardiovascular mortality in patients with non-insulin-dependent diabetes: a brief overview of microalbuminuria and insulin resistance.
Academic Article Effect of calcium channel or beta-blockade on the progression of diabetic nephropathy in African Americans.
Academic Article Renal mortality associated with non-insulin-dependent diabetes mellitus.
Academic Article Benefits of combination angiotensin-converting enzyme inhibitor and calcium antagonist therapy for diabetic patients.
Academic Article Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy.
Academic Article Microalbuminuria: what is it? Why is it important? What should be done about it?
Academic Article Antihypertensive therapy and the risk of type 2 diabetes mellitus.
Academic Article Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy.
Academic Article Risks for renal involvement in diabetes.
Academic Article Type 2 diabetes: RENAAL and IDNT--the emergence of new treatment options.
Academic Article Oral antidiabetic agents safe with renal disease?
Academic Article Impact of an ACE inhibitor and calcium antagonist on microalbuminuria and lipid subfractions in type 2 diabetes: a randomised, multi-centre pilot study.
Academic Article The evolution of treatment guidelines for diabetic nephropathy. Strategies integrate JNC VI, more recent protocols.
Academic Article Risk for renal injury in diabetic hypertensive patients. The physiologic basis for blood pressure control.
Academic Article Risk for renal injury in diabetic hypertensive patients. Pharmacologic approaches.
Academic Article Achieving goal blood pressure in patients with type 2 diabetes: conventional versus fixed-dose combination approaches.
Academic Article Hypertension and nephropathy.
Academic Article Rosiglitazone reduces urinary albumin excretion in type II diabetes.
Academic Article How high should an ACE inhibitor or angiotensin receptor blocker be dosed in patients with diabetic nephropathy?
Academic Article What have we learned from the current trials?
Academic Article Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.
Academic Article When does new onset diabetes resulting from antihypertensive therapy increase cardiovascular risk.
Academic Article Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes.
Academic Article Rosiglitazone reduces microalbuminuria and blood pressure independently of glycemia in type 2 diabetes patients with microalbuminuria.
Academic Article Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetes.
Academic Article Antihypertensive agents, insulin sensitivity, and new-onset diabetes.
Academic Article Effect of fixed-dose ACE-inhibitor/calcium channel blocker combination therapy vs. ACE-inhibitor monotherapy on arterial compliance in hypertensive patients with type 2 diabetes.
Academic Article The efficacy and safety of low- and high-dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trial.
Academic Article Clinical importance of microalbuminuria in diabetes and hypertension.
Academic Article Antihypertensive treatment with beta-blockers and the spectrum of glycaemic control.
Academic Article beta-blocker use and diabetes symptom score: results from the GEMINI study.
Academic Article Effects of different calcium antagonists on proteinuria associated with diabetes mellitus.
Academic Article The ADVANCE trial: further PROGRESS with HOPE.
Academic Article Risk factor assessment for new onset diabetes: literature review.
Academic Article Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk.
Academic Article Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI Trial.
Academic Article The JNC 7 approach compared to conventional treatment in diabetic patients with hypertension: a double-blind trial of initial monotherapy vs. combination therapy.
Academic Article Intervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResión Arterial en DIabéticos tipo Dos) study.
Academic Article Rationale and design of a study comparing two fixed-dose combination regimens to reduce albuminuria in patients with type II diabetes and hypertension.
Academic Article Effects of thiazolidinediones beyond glycaemic control.
Academic Article Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients.
Academic Article Glycemic control and cardiovascular disease in chronic kidney disease.
Academic Article Inhibiting the renin-angiotensin system in patients with type 1 diabetes: is it worth it?
Academic Article The effect of ruboxistaurin on nephropathy in type 2 diabetes.
Academic Article Effect of ruboxistaurin on urinary transforming growth factor-beta in patients with diabetic nephropathy and type 2 diabetes.
Academic Article Antihypertensive efficacy of Irbesartan/HCTZ in men and women with the metabolic syndrome and type 2 diabetes.
Academic Article Protection of the kidney by thiazolidinediones: an assessment from bench to bedside.
Academic Article Lower blood pressure goals in high-risk cardiovascular patients: are they defensible?
Academic Article Should all patients with type 2 diabetes receive initial combination therapy: an assessment of the ADVANCE trial.
Academic Article Limitations of metformin use in patients with kidney disease: are they warranted?
Academic Article EXamination of cArdiovascular outcoMes with alogliptIN versus standard of carE in patients with type 2 diabetes mellitus and acute coronary syndrome (EXAMINE): a cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes with acute coronary syndrome.
Academic Article Pros and cons of aggressive blood pressure lowering in patients with type 2 diabetes.
Academic Article Single-pill combination of telmisartan/amlodipine versus amlodipine monotherapy in diabetic hypertensive patients: an 8-week randomized, parallel-group, double-blind trial.
Academic Article Mechanistic insights into diuretic-induced insulin resistance.
Academic Article Management of hypertension in patients with diabetes: the place of angiotensin-II receptor blockers.
Academic Article Prevention of microalbuminuria in patients with type 2 diabetes: what do we know?
Academic Article Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.
Academic Article National Kidney Foundation consensus conference on cardiovascular and kidney diseases and diabetes risk: an integrated therapeutic approach to reduce events.
Academic Article Optimal blood pressure for a patient with type 2 diabetes mellitus: insight from the ACCORD study.
Academic Article Do fibrates truly preserve kidney function?
Academic Article Telmisartan in incipient and overt diabetic renal disease.
Academic Article Metabolic effects of beta-blockers: importance of dissociating newer from conventional agents.
Academic Article Hypertension in diabetic patients: an update of interventional studies to preserve renal function.
Academic Article ACE inhibitor mediated reductions in renal size and microalbuminuria in normotensive, diabetic subjects.
Academic Article Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection.
Academic Article Differential effect of beta-blocker therapy on insulin resistance as a function of insulin sensitizer use: results from GEMINI.
Academic Article Body weight changes with beta-blocker use: results from GEMINI.
Academic Article Trials that matter: the effect of a fixed-dose combination of an Angiotensin-converting enzyme inhibitor and a diuretic on the complications of type 2 diabetes.
Academic Article Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study.
Academic Article Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) study.
Academic Article Microalbuminuria in non-insulin-dependent diabetes mellitus. Implications for renal survival.
Academic Article Recognition, pathogenesis, and treatment of different stages of nephropathy in patients with type 2 diabetes mellitus.
Academic Article Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.
Academic Article Angiotensin converting enzyme inhibitors or angiotensin receptor blockers in nephropathy from type 2 diabetes.
Academic Article ACE inhibitors and protection against kidney disease progression in patients with type 2 diabetes: what's the evidence.
Academic Article Blood pressure, antihypertensive therapy and risk for renal injury in African-Americans.
Academic Article Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.
Academic Article Pathogenesis and treatment of microalbuminuria in patients with diabetes: the road ahead.
Academic Article Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease.
Academic Article Rationale and trial design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON).
Academic Article Effects of nebivolol on aortic compliance in patients with diabetes and maximal renin angiotensin system blockade: the EFFORT study.
Academic Article Clinical guidelines: blood pressure goals in T2DM: a Latin American perspective.
Academic Article Use of a single target blood pressure level in type 2 diabetes mellitus for all cardiovascular risk reduction: comment on "intensive and standard blood pressure targets in patients with type 2 diabetes mellitus".
Academic Article Randomized study of antihypertensive efficacy and safety of combination aliskiren/valsartan vs valsartan monotherapy in hypertensive participants with type 2 diabetes mellitus.
Academic Article Risk factors for heart failure in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl.
Academic Article Diabetic kidney disease: a report from an ADA Consensus Conference.
Academic Article Microalbuminuria as a risk predictor in diabetes: the continuing saga.
Academic Article Evidence-based triple antihypertensive therapy yields lower mortality in older patients with diabetes mellitus.
Academic Article Metformin nephrotoxicity insights: will they change clinical management?
Academic Article Diabetic kidney disease: a report from an ADA Consensus Conference.
Academic Article Efficacy and safety of canagliflozin in patients with type 2 diabetes and stage 3 nephropathy.
Academic Article Mechanisms contributing to adverse cardiovascular events in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl.
Academic Article Renin inhibition in patients with chronic kidney disease: is it conclusively non-indicated?
Academic Article Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.
Academic Article Alogliptin after acute coronary syndrome in patients with type 2 diabetes.
Academic Article Determinants and changes associated with aldosterone breakthrough after angiotensin II receptor blockade in patients with type 2 diabetes with overt nephropathy.
Academic Article Lowering blood pressure limits in patients with type 2 diabetes: is it still warranted?
Academic Article Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial.
Academic Article In search for the 'sweet spot' for blood pressure level in diabetes.
Academic Article Rationale, design, and baseline characteristics of ARTS-DN: a randomized study to assess the safety and efficacy of finerenone in patients with type 2 diabetes mellitus and a clinical diagnosis of diabetic nephropathy.
Academic Article Blood pressure reduction: an added benefit of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes.
Academic Article Update on blood pressure goals in diabetes mellitus.
Academic Article Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial.
Academic Article Hypertension: Impact of blood pressure lowering in type 2 diabetes.
Academic Article Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial.
Academic Article Finerenone for Albuminuria in Patients With Diabetic Nephropathy--Reply.
Academic Article Hypertension: SGLT2 inhibitors: not just another glucose-lowering agent.
Academic Article Management of Hypertension in Diabetic Nephropathy: How Low Should We Go?
Academic Article Effects of azilsartan medoxomil compared with olmesartan and valsartan on ambulatory and clinic blood pressure in patients with type 2 diabetes and prediabetes.
Academic Article Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH Substudy.
Academic Article Ischemic cardiac outcomes and hospitalizations according to prior macrovascular disease status in patients with type 2 diabetes and recent acute coronary syndrome from the Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care trial.
Academic Article Cardiovascular Mortality in Patients With Type 2 Diabetes and Recent Acute Coronary Syndromes From the EXAMINE Trial.
Academic Article Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? Yes, They Should Be Relaxed! What's the Fuss?
Academic Article Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor Alogliptin.
Academic Article Diabetes: Blood pressure goals in T2DM - time for a rethink?
Academic Article Effect of Sitagliptin on Kidney Function and Respective Cardiovascular Outcomes in Type 2 Diabetes: Outcomes From TECOS.
Academic Article Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial.
Academic Article Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis.
Academic Article Serial Measurement of High-Sensitivity Troponin I and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus in the EXAMINE Trial (Examination of Cardiovascular Outcomes With Alogliptin Versus Standard of Care).
Academic Article Sodium/Glucose Cotransporter 2 Inhibitors in Patients With Diabetes Mellitus and Chronic Kidney Disease: Turning the Page.
Academic Article Baseline characteristics and enrichment results from the SONAR trial.
Academic Article Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy.
Academic Article High-sensitivity C-reactive protein, low-density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care) trial.
Academic Article Prevalent and Incident Heart Failure in Cardiovascular Outcome Trials of Patients With Type 2 Diabetes.
Academic Article Nonsteroidal mineralocorticoid antagonists in diabetic kidney disease.
Academic Article Early and Chronic Dipeptidyl-Peptidase-IV Inhibition and Cardiovascular Events in Patients With Type 2 Diabetes Mellitus After an Acute Coronary Syndrome: A Landmark Analysis of the EXAMINE Trial.
Academic Article Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study.
Academic Article Blood Pressure Control and Cardiovascular/Renal Outcomes.
Academic Article Relation of Serum and Urine Renal Biomarkers to Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Recent Acute Coronary Syndromes (From the EXAMINE Trial).
Academic Article Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function.
Academic Article Kidney Biomarkers and Decline in eGFR in Patients with Type 2 Diabetes.
Academic Article SGLT2 Inhibitors and Mechanisms of Hypertension.
Academic Article Average Clinician-Measured Blood Pressures and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Ischemic Heart Disease in the EXAMINE Trial.
Academic Article Diabetic Kidney Disease: A Determinant of Cardiovascular Risk in Type 1 Diabetes.
Academic Article Results of ACCORDIAN in ACCORD with lower blood pressure begetting lower mortality in patients with diabetes.
Academic Article Are All Patients With Type 1 Diabetes Destined for Dialysis if They Live Long Enough? Probably Not.
Academic Article Creatinine Bump Following Antihypertensive Therapy.
Academic Article Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Academic Article Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.
Academic Article Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups.
Academic Article Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial.
Academic Article Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
Academic Article Chronic Kidney Disease in Type 2 Diabetes: Optimizing Glucose-Lowering Therapy.
Academic Article Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c <7%: Results From the CREDENCE Trial.
Academic Article Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial.
Academic Article Use of sodium-glucose co-transporter-2 inhibitors in patients with and without type 2 diabetes: implications for incident and prevalent heart failure.
Academic Article Clinical and Biomarker Predictors of Expanded Heart Failure Outcomes in Patients With Type 2 Diabetes Mellitus After a Recent Acute Coronary Syndrome: Insights From the EXAMINE Trial.
Academic Article Prediction and validation of exenatide risk marker effects on progression of renal disease: Insights from EXSCEL.
Academic Article Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial.
Academic Article Diastolic Blood Pressure Does Not Influence Cardiovascular Outcomes in Type 2 Diabetes; or Does It?
Academic Article Timing of randomization after an acute coronary syndrome in patients with type 2 diabetes mellitus.
Academic Article Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial.
Academic Article Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine.
Academic Article Inter-individual variability in atrasentan exposure partly explains variability in kidney protection and fluid retention responses: A post hoc analysis of the SONAR trial.
Academic Article Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.
Academic Article Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice.
Academic Article Individual Atrasentan Exposure is Associated With Long-term Kidney and Heart Failure Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease.
Academic Article Effects of canagliflozin on cardiovascular, renal, and safety outcomes in participants with type 2 diabetes and chronic kidney disease according to history of heart failure: Results from the CREDENCE trial.
Academic Article Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights From the CREDENCE Trial.
Academic Article Red cell distribution width in patients with diabetes and myocardial infarction: An analysis from the EXAMINE trial.
Academic Article Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes. Reply.
Academic Article The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: Analysis of the CREDENCE trial.

Search Criteria
  • Diabetes Mellitus Adult Onset